Ledger.Open graph →

SEC Form D · filed May 15, 2018

Cotinga Pharmaceuticals Inc

Offering

$1.6M

Sold

$1.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

LONDON, Ontario, Canada

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Alison S. Silva · LONDON, Ontario, CanadaExec · Director John S. Yoo · LONDON, Ontario, CanadaDirector John C. Drake · LONDON, Ontario, CanadaDirector David S. Sanderson · LONDON, Ontario, CanadaDirector Gene Kelly · LONDON, Ontario, CanadaExec Douglas S. Alexander · LONDON, Ontario, CanadaDirector Thomas C. Defilipps · Redwood City, CADirector Alexandra Shadle · SAN FRANCISCO, CADirector David R. Hirsch · Austin, TXExec Jeremiah Daly · Clearwater, FLExec · Director Kevin M. Lalande · Austin, TXDirector Eric E. Poma · Austin, TXDirector Justin J. Grissen · Dallas, TXExec · Director Steve A. Thomas · New York, NYDirector Greg R. Madden · MARLBOROUGH, MADirector Joe Lonsdale · Santa Ana, CADirector Jennifer Justice · Santa Ana, CAExec Erik Anderson · Santa Ana, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗